To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Cholinergic properties of… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Cholinergic properties of new 7-methoxytacrine-donepezil derivatives.

Journal article
Authors Vendula Sepsova
Jana Z Karasova
Gunnar Tobin
Daniel Jun
Jan Korabecny
Pavla Cabelova
Katerina Janska
Jan Krusek
Kristyna Skrenkova
Kamil Kuca
Ondrej Soukup
Published in General physiology and biophysics
Volume 34
Issue 2
Pages 189-200
ISSN 0231-5882
Publication year 2015
Published at Institute of Neuroscience and Physiology, Department of Pharmacology
Pages 189-200
Language en
Subject categories Pharmacology


Organophosphorus nerve agents inhibit acetylcholinesterase (AChE) which causes the breakdown of the transmitter acetylcholine (ACh) in the synaptic cleft. Overstimulation of cholinergic receptors (muscarinic and nicotinic) by excessive amounts of ACh causes several health problems and may even cause death. Reversible AChE inhibitors play an important role in prophylaxis against nerve agents. The presented study investigated whether 7-methoxytacrine (7-MEOTA) and 7-MEOTA-donepezil derivatives can act as central and peripheral reversible AChE inhibitors and simultaneously antagonize muscarinic and nicotinic receptors. The possible mechanism of action was studied on cell cultures (patch clamp technique, calcium mobilization assay) and on isolated smooth muscle tissue (contraction study). Furthermore, the kinetics of the compounds were also examined. CNS availability was predicted by determining the passive blood-brain barrier penetration estimated via a modified PAMPA assay. In conclusion, this study provides promising evidence that the new synthesized 7-MEOTA-donepezil derivatives have the desired anticholinergic effect; they can inhibit AChE, and nicotinic and muscarinic receptors in the micromolar range. Furthermore, they seem to penetrate readily into the CNS. However, their real potency and benefit must be verified by in vivo experiments.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?